Amendment: SEC Form SCHEDULE 13G/A filed by enGene Holdings Inc.
$ENGN
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)*
|
enGene Holdings Inc. (Name of Issuer) |
Common Shares (Title of Class of Securities) |
29286M105 (CUSIP Number) |
09/30/2024 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 29286M105 |
| 1 | Names of Reporting Persons
Fonds de solidarite des travailleurs et des travailleuses du Quebec | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
QUEBEC, CANADA
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,029,751.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.5 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IV |
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
enGene Holdings Inc. | |
| (b) | Address of issuer's principal executive offices:
4868 rue Levy, Suite 220, Saint-Laurent, Quebec, Canada H4R 2P1 | |
| Item 2. | ||
| (a) | Name of person filing:
Fonds de solidarite des travailleurs et des travailleuses du Quebec | |
| (b) | Address or principal business office or, if none, residence:
545, Cremazie Blvd. East, Suite 200
Montreal, Quebec, CANADA
H2M 2W4 | |
| (c) | Citizenship:
Quebec, Canada | |
| (d) | Title of class of securities:
Common Shares | |
| (e) | CUSIP No.:
29286M105 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
2,029,751 common shares (the sum of 1,583,179 common shares and 446,572 common shares issuable upon the exercise of 446,572 warrants). | |
| (b) | Percent of class:
4.5%, based on 44,662,149 common shares, the sum of (i) 44,215,577 common shares outstanding as of September 6, 2024, as reported in enGene Holdings Inc.'s Form 10-Q filed with the U.S. Securities and Exchange Commission on September 10, 2024 and (ii) 446,572 common shares that would result in the event that all of the 446,572 warrants held by the reporting person were exercised and no other outstanding warrants were exercised.
4.5 %
| |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
See row 5 of cover page. | ||
| (ii) Shared power to vote or to direct the vote:
See row 6 of cover page. | ||
| (iii) Sole power to dispose or to direct the disposition of:
See row 7 of cover page. | ||
| (iv) Shared power to dispose or to direct the disposition of:
See row 8 of cover page. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
|
Ownership of 5 percent or less of a class
| ||
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|